Our Services
Medical Information
Helpful Resources
Published on: 9/17/2026
Yes, both seasonal allergies and asthma are among the most common reasons for a high eosinophil count, since these white blood cells are released as part of the immune system's allergic response. Mild elevations often rise and fall with pollen exposure, flare-ups, or medication changes, while persistently high counts can point to other causes such as parasitic infection, drug reactions, eczema, or rarer inflammatory conditions. The specific number on your lab report matters, because moderate to severe elevations are interpreted very differently than borderline ones. There are several important details and warning signs to consider before assuming allergies are the only explanation, so see below to understand more.
If you are trying to make sense of an elevated eosinophil result, the fastest way to organize your symptoms is to run a free, instant, online symptom check that maps what you are experiencing against likely causes and tells you how urgently to follow up, so you walk into your next appointment with clear questions instead of guesswork.
Last reviewed for medical accuracy: 09/17/2026
Eosinophils are a type of white blood cell that play a key role in your immune system. They help defend against parasites and contribute to the body’s inflammatory response. When eosinophil levels rise above the normal range, the condition is called eosinophilia. You may wonder whether common conditions like seasonal allergies or asthma can push eosinophils higher—and what that means for your health.
• Eosinophils develop in the bone marrow and circulate in the bloodstream.
• They migrate into tissues—especially the lungs, skin, and gastrointestinal tract—where they release proteins and chemicals to fight off invaders.
• In moderate amounts, their activity helps protect against infections. In excess, it can cause unwanted inflammation.
• Expressed as an absolute count (cells per microliter of blood) or a percentage of total white blood cells.
• Typical reference ranges:
While seasonal allergies and asthma are important triggers, other causes include:
• Parasitic infections (e.g., certain worms)
• Autoimmune diseases (e.g., eosinophilic granulomatosis)
• Drug reactions (some antibiotics, nonsteroidal anti-inflammatory drugs)
• Skin conditions (e.g., eczema)
• Gastrointestinal disorders (e.g., eosinophilic esophagitis)
• Some cancers (rarely, certain leukemias)
Seasonal allergies (hay fever) occur when your immune system overreacts to airborne allergens such as pollen, mold spores, or grass. Here’s how they relate to eosinophils:
Symptoms often include sneezing, watery eyes, nasal congestion, and post-nasal drip. Blood tests during high-exposure months may show mild to moderate eosinophilia. This is generally a reversible process: once the allergy season ends and inflammation subsides, eosinophil levels usually return to normal.
Asthma is a chronic airway condition characterized by bronchial inflammation and hyperresponsiveness. A subtype known as eosinophilic asthma involves elevated eosinophils in the airways and blood. Key points:
Blood tests showing elevated eosinophils alongside classic asthma symptoms (shortness of breath, chest tightness, wheeze) often point to eosinophilic asthma. Specialized inhalers and biologic therapies that target IL-5 have been developed to reduce eosinophil levels and improve control.
Mild eosinophilia related to allergies or asthma can be a normal part of the inflammatory response. However, certain patterns warrant further evaluation:
• Persistent elevation above 1,500 cells/µL
• Rapidly rising counts over weeks
• Unexplained symptoms: weight loss, fever, night sweats
• Signs of organ involvement: breathing difficulty, skin rash, abdominal pain
• Lack of improvement with allergy or asthma treatment
If you fall into any of these categories, a healthcare provider may order additional tests—imaging, specialized blood panels, or tissue biopsies—to rule out rarer causes like parasitic infections, autoimmune conditions, or blood cancers.
Track Your Symptoms
• Note timing (seasonal versus year-round)
• Record triggers (pollen, pets, exercise, stress)
• Monitor response to medications
Discuss Lab Results
• Bring eosinophil counts to your doctor’s attention
• Compare values across different seasons or flare-ups
• Ask about additional testing if counts remain high
Explore Targeted Treatments
• Allergy immunotherapy (allergy shots or sublingual tablets)
• Inhaled corticosteroids or leukotriene modifiers for asthma
• Biologic drugs targeting IL-5 or IgE in severe cases
Consider a quick, free, online symptom check
If you’re unsure what’s driving your coughing, sneezing, or blood test results, try a free, online symptom check, using the doctor approved Ubie Symptom Checker. You’ll get personalized guidance on whether eosinophilia is likely linked to allergy, asthma, or something else.
Eosinophil counts offer valuable clues, but they’re only one piece of the puzzle. Always discuss abnormal labs or troubling symptoms with a qualified healthcare provider. They can:
• Interpret results in the context of your medical history
• Order further tests if needed
• Recommend specialists (allergist, pulmonologist, immunologist)
• Develop a treatment plan to manage inflammation and improve quality of life
If you experience severe breathing difficulty, chest pain, high fever, or any symptom that feels life-threatening, seek emergency care immediately.
Always consult a healthcare professional to confirm the cause of elevated eosinophils and to rule out serious conditions. Speak to a doctor about any symptoms that are severe, worsening, or causing significant concern.
(References)
* Sukhan VS. Allergic rhinitis and asthma co-morbidity. Wiad Lek. 2019;72(4):622-626. PMID: 31055544.
* Jackson DJ, Akuthota P, Roufosse F. Eosinophils and eosinophilic immune dysfunction in health and disease. Eur Respir Rev. 2022 Mar 31;31(163). doi: 10.1183/16000617.0150-2021. Epub 2022 Jan 25. PMID: 35082127; PMCID: PMC9489126.
* Maison N, Omony J, Illi S, Thiele D, Skevaki C, Dittrich AM, Bahmer T, Rabe KF, Weckmann M, Happle C, Schaub B, Meyer M, Foth S, Rietschel E, Renz H, Hansen G, Kopp MV, von Mutius E, Grychtol R, ALLIANCE Study Group, ALLIANCE Study Group, Fuchs O, Roesler B, Welchering N, Kohistani-Greif N, Kurz J, Landgraf-Rauf K, Laubhahn K, Liebl C, Ege M, Hose A, Zeitlmann E, Berbig M, Marzi C, Schauberger C, Zissler U, Schmidt-Weber C, Ricklefs I, Diekmann G, Liboschik L, Voigt G, Sultansei L, Nissen G, König IR, Kirsten AM, Pedersen F, Watz H, Waschki B, Herzmann C, Abdo M, Biller H, Gaede KI, Bovermann X, Steinmetz A, Husstedt BL, Nitsche C, Veith V, Szewczyk M, Brinkmann F, Malik A, Schwerk N, Dopfer C, Price M, Jirmo AC, Habener A, DeLuca DS, Gaedcke S, Liu B, Calveron MR, Weber S, Schildberg T, van Koningsbruggen-Rietschel S, Alcazar M. T2-high asthma phenotypes across lifespan. Eur Respir J. 2022 Sep;60(3). doi: 10.1183/13993003.02288-2021. Epub 2022 Sep 29. PMID: 35210326; PMCID: PMC9520028.
* Wechsler ME, Klion AD, Paggiaro P, Nair P, Staumont-Salle D, Radwan A, Johnson RR, Kapoor U, Khokhar FA, Daizadeh N, Chen Z, Laws E, Ortiz B, Jacob-Nara JA, Mannent LP, Rowe PJ, Deniz Y. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis. J Allergy Clin Immunol Pract. 2022 Oct;10(10):2695-2709. doi: 10.1016/j.jaip.2022.05.019. Epub 2022 May 28. PMID: 35636689.
* Khoury P, Akuthota P, Kwon N, Steinfeld J, Roufosse F. HES and EGPA: Two Sides of the Same Coin. Mayo Clin Proc. 2023 Jul;98(7):1054-1070. doi: 10.1016/j.mayocp.2023.02.013. PMID: 37419574; PMCID: PMC10348452.
* Solans-Laqué R, Rúa-Figueroa I, Blanco Aparicio M, García Moguel I, Blanco R, Pérez Grimaldi F, Noblejas Mozo A, Labrador Horrillo M, Álvaro-Gracia JM, Domingo Ribas C, Espigol-Frigolé G, Sánchez-Toril López F, Ortiz Sanjuán FM, Arismendi E, Cid MC. Red flags for clinical suspicion of eosinophilic granulomatosis with polyangiitis (EGPA). Eur J Intern Med. 2024 Oct;128:45-52. doi: 10.1016/j.ejim.2024.06.008. Epub 2024 Jun 15. PMID: 38880725.
* Gauvreau GM, Sehmi R, FitzGerald JM, Leigh R, Cockcroft DW, Davis BE, Mayers I, Boulet LP, Al-Sajee D, Salter BM, Cusack RP, Ho T, Whetstone CE, Alsaji N, Satia I, Killian KJ, Mitchell PD, Magee IP, Bergeron C, Bhutani M, Werkström V, Durżyński T, Shoemaker K, Katial RK, Jison M, Newbold P, McCrae C, O'Byrne PM. Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trial. Eur Respir J. 2024 Sep;64(3). doi: 10.1183/13993003.00512-2024. Epub 2024 Sep 12. PMID: 39060015; PMCID: PMC11391094.
* Jackson DJ, Wechsler ME, Brusselle G, Buhl R. Targeting the IL-5 pathway in eosinophilic asthma: A comparison of anti-IL-5 versus anti-IL-5 receptor agents. Allergy. 2024 Nov;79(11):2943-2952. doi: 10.1111/all.16346. Epub 2024 Oct 12. PMID: 39396109.
* Sunata K, Miyata J, Kawashima Y, Konno R, Ishikawa M, Hasegawa Y, Onozato R, Otsu Y, Matsuyama E, Sasaki H, Okuzumi S, Mochimaru T, Masaki K, Kabata H, Chubachi S, Arita M, Fukunaga K. Inflammatory profile of eosinophils in asthma-COPD overlap and eosinophilic COPD: a multi-omics study. Front Immunol. 2024;15:1445769. doi: 10.3389/fimmu.2024.1445769. Epub 2024 Oct 8. PMID: 39439801; PMCID: PMC11493663.
* Lommatzsch M, Buhl R, Bergmann KC, Brusselle GG, Canonica GW, Jackson DJ, Heaney LG, Nair P, Virchow JC. Eosinophils in asthma phenotypes: perpetrators or guilty by association? Lancet Respir Med. 2025 Oct;13(10):943-950. doi: 10.1016/S2213-2600(25)00174-2. Epub 2025 Jul 8. PMID: 40645201.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.